Literature DB >> 11099315

Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.

J Sayós1, K B Nguyen, C Wu, S E Stepp, D Howie, J D Schatzle, V Kumar, C A Biron, C Terhorst.   

Abstract

SAP, the gene that is altered or absent in the X-linked lymphoproliferative syndrome (XLP), encodes a small protein that comprises a single SH2 domain and binds to the cell-surface protein SLAM which is present on activated or memory T and B cells. Because defective NK cell activity also has been reported in XLP patients, we studied the SAP gene in NK cells. SAP was induced upon viral infection of SCID mice and shown to be expressed in NK cells by in vitro culturing in the presence of IL-2. Moreover, SAP was expressed in the NK cell lines YT and RNK 16. Because SLAM, the cell-surface protein with which SAP interacts, and 2B4, a membrane protein having sequence homologies with SLAM, also were found to be expressed on the surfaces of activated NK and T cell populations, they may access SAP functions in these populations. Whereas we found that 2B4 also binds SAP, 2B4-SAP interactions occurred only upon tyrosine phosphorylation of 2B4. By contrast, SLAM-SAP interactions were independent of phosphorylation of Y281 and Y327 on SLAM. As CD48, the ligand for 2B4, is expressed on the surface of Epstein-Barr virus (EBV)-infected B cells, it is likely that SAP regulates signal transduction through this pair of cell-surface molecules. These data support the hypothesis that XLP is a result of both defective NK and T lymphocyte responses to EBV. The altered responses may be due to aberrant control of the signaling cascades which are initiated by the SLAM-SLAM and 2B4-CD48 interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099315     DOI: 10.1093/intimm/12.12.1749

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.

Authors:  Anna Lissina; David R Ambrozak; Kristin L Boswell; Wenjing Yang; Eli Boritz; Yoshiyuki Wakabayashi; Maria C Iglesias; Masao Hashimoto; Masafumi Takiguchi; Elias Haddad; Daniel C Douek; Jun Zhu; Richard A Koup; Takuya Yamamoto; Victor Appay
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

2.  Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.

Authors:  Stephen N Waggoner; Ruth T Taniguchi; Porunelloor A Mathew; Vinay Kumar; Raymond M Welsh
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

3.  Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP.

Authors:  M J Czar; E N Kersh; L A Mijares; G Lanier; J Lewis; G Yap; A Chen; A Sher; C S Duckett; R Ahmed; P L Schwartzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

4.  Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.

Authors:  M Morra; J Lu; F Poy; M Martin; J Sayos; S Calpe; C Gullo; D Howie; S Rietdijk; A Thompson; A J Coyle; C Denny; M B Yaffe; P Engel; M J Eck; C Terhorst
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse.

Authors:  Ninghai Wang; Silvia Calpe; Jill Westcott; Wilson Castro; Chunyan Ma; Pablo Engel; John D Schatzle; Cox Terhorst
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

6.  Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions.

Authors:  Kyung-Mi Lee; John P Forman; Megan E McNerney; Susan Stepp; Sumalatha Kuppireddi; Dustin Guzior; Yvette E Latchman; Mohamed H Sayegh; Hideo Yagita; Chul-Kyu Park; Seog Bae Oh; Christoph Wülfing; John Schatzle; Porunelloor A Mathew; Arlene H Sharpe; Vinay Kumar
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

Review 7.  X-linked lymphoproliferative disease: genetic lesions and clinical consequences.

Authors:  Andrew J MacGinnitie; Raif Geha
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.806

Review 8.  X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses.

Authors:  Hamid Bassiri; W C Janice Yeo; Jennifer Rothman; Gary A Koretzky; Kim E Nichols
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.

Authors:  Yoshimi Enose-Akahata; Eiji Matsuura; Unsong Oh; Steven Jacobson
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

10.  Development and characterization of domain-specific monoclonal antibodies produced against human SLAMF9.

Authors:  Olga Volkova; Sergey Guselnikov; Ludmila Mechetina; Nicolai Chikaev; Konstantin Baranov; Sergey Kulemzin; Evdokiya Reshetnikova; Alexander Najakshin; Alexander Taranin
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.